Ophthalmology 6 - 7 July 2018 Genoa (Italy) - GOA Ophtalmology 2018 | Esaso Retina Forum
←
→
Trascrizione del contenuto della pagina
Se il tuo browser non visualizza correttamente la pagina, ti preghiamo di leggere il contenuto della pagina quaggiù
_ophthalmology
and
Esaso Retina Forum
6 - 7 July 2018 Genoa (Italy)
Final
Program
1
6 July 2018 Genoa (Italy) 7 July 2018
_ophthalmology GOA Ophthalmology ESASO Retina Forum
UNDER THE AUSPICES OF
COMUNE DI GENOVA
2
6 July 2018 Genoa (Italy) 7 July 2018
_ophthalmology GOA Ophthalmology ESASO Retina Forum
WELCOME
Dear Friends and Colleagues,
We are delighted to welcome you to the GOA_ophthalmology International Course and
ESASO Retina Forum, which will be held in Genova July 6th - 7th, 2018.
Clinically relevant topics as retina diagnostics, cataract, glaucoma, cornea, vitreoretinal
surgery, strabismus and others will be covered by Key Opinion Leaders.
This will be a great occasion for exchange, update and networking and a good reason to visit
beautiful Genova and the Italian Riviera at the beginning of the summer.
Looking forward to welcoming you here.
Carlo E. Traverso
CONTENTS
Faculty page 4
Scientific Program page 5
Sponsored Symposia page 7
General Information page 8
CME Accreditation page 9
Acknowledgments page 10
3
6 July 2018 Genoa (Italy) 7 July 2018
_ophthalmology GOA Ophthalmology ESASO Retina Forum
FACULTY
President
Carlo Enrico Traverso
Goa_ophthalmology Esaso Retina Forum
Friday, 6 July 2018 Saturday, 7 July 2018
Course Director Course Director
Michele Iester Massimo Nicolò
Teresio Avitabile (Italy) Matteo Badino (Italy)
Francesco Bandello (Italy) Francesco Bandello (Italy)
Maurizio Battaglia Parodi (Italy) Maurizio Battaglia Parodi (Italy)
Lucio Buratto (Italy) Francesco Boscia (Italy)
Massimo Busin (Italy) Borja Corcóstegui (Spain)
Francesco Calcagno (Italy) Sandro De Falco (Italy)
Emilio Campos (Italy) Claudio Furino (Italy)
Paolo Capris (Italy) Michele Iester (Italy)
Ettore Ferrari (Italy) Paolo Lanzetta (Italy)
Claudio Furino (Italy) Marco Lupidi (Italy)
Fabio Giacomelli (Italy)
Leonardo Mastropasqua (Italy)
Michele Iester (Italy)
Zofia Michalewska (Poland)
Leonardo Mastropasqua (Italy)
Daniel Mojon (Switzerland)
Danilo Renato Mazzacane (Italy)
Ugo Murialdo (Italy)
Frances Meier-Gibbons (Switzerland)
Massimo Nicolò (Italy)
Zofia Michalewska (Poland)
Tommaso Rossi (Italy)
Carlo Mosci (Italy)
Carlo Enrico Traverso (Italy)
Ugo Murialdo (Italy)
Massimo Nicolò (Italy)
Paolo Nucci (Italy)
Maurizio Postorino (Italy)
Stanislao Rizzo (Italy)
Tommaso Rossi (Italy)
Sergio Saccà (Italy)
Fotis Topouzis (Greece)
Stela Vujosevic (Italy)
4
_ophthalmology 6 July 2018
SCIENTIFIC PROGRAM
08.30 Registration
09.30 SESSION I
10.30 Chairman: Teresio Avitabile
Facilitators: Francesco Calcagno, Paolo Capris
09.30 Cataract surgery: state of the art - Lucio Buratto
09.50 The final cut: DSAEK vs DMEK - Massimo Busin
10.10 Discussion
10.30 OPENING SESSION
Welcome and introductions
Aknowledgement of the Ines Malerba Association
11.00 Break
11.30 SESSION II
12.30 Chairman: Teresio Avitabile
Facilitators: Ettore Ferrari, Carlo Mosci
11.30 Femtolaser corneal surgery - Leonardo Mastropasqua
11.50 Citicoline in oral solution: rational and protocol for an international and multicentric RCT on quality of
life in glaucomatous patients - Fotis Topouzis
12.10 Discussion
12.30 Lunch break - Sponsored Symposium (see page 7)
14.00 SESSION III
15.30 Chairman: Fabio Giacomelli
Facilitators: Danilo Renato Mazzacane, Maurizio Postorino
14.00 OCT and angio OCT. How do they fit in the real life - Zofia Michalewska
14.15 Pathophysiology of trabecular meshwork - Sergio Saccà
14.30 What you always wanted to know about generic drugs - Frances Meier-Gibbons
14.45 Modern management of amblyopia - Emilio Campos
15.00 Discussion
15.30 SESSION IV
17.00 Chairman: Francesco Bandello
Facilitators: Ugo Murialdo, Tommaso Rossi
15.30 Imaging and perimetry - Michele Iester
15.45 Strabismus management: what I won’t do anymore - Paolo Nucci
16.00 Diabetic retinopathy decision-making - Francesco Bandello
16.15 Retinal prosthesis - Stanislao Rizzo
16.30 Discussion
5
Retina Forum 7 July 2018
SCIENTIFIC PROGRAM
09.15 SESSION I
10.25 Chairman: Borja Corcóstegui
Facilitators: Francesco Bandello, Ugo Murialdo
09.15 Stickler disease update in diagnosis and treatment - Borja Corcóstegui
09.25 Head up surgery in DME and PDR - Matteo Badino
09.35 Retinal surprises - Daniel Mojon
09.45 Vitrectomy fluidics in advanced vitreo-retinal surgery - Tommaso Rossi
09.55 Clinico-tomographic correlations before and after macular hole surgery - Zofia Michalewska
10.05 Discussion
10.25 Break
11.00 Sponsored Symposium (see page 7)
12.00
12.00 SESSION II
13.00 Chairman: Francesco Bandello
Facilitator: Felice Cardillo Piccolino
12.00 Management of rhegmatogenous retinal detachment - Zofia Michalewska
12.10 Complications of degenerative retinoschisis - Borja Corcóstegui
12.20 Microvascular circulation in diabetic retinopathy - Marco Lupidi
12.30
Angio-OCT and RAP - Massimo Nicolò
12.40 Discussion
13.00 LUNCH BREAK SYMPOSIUM
14.00 Cataract surgery in diabetic macular edema or glaucoma patients: new perspectives
Chairmen: Michele Iester, Massimo Nicolò
13.00 Cataract surgery in patients with DME and glaucoma: problem definition - Francesco Boscia
13.20 Cataract surgery in glaucoma patients - Carlo Enrico Traverso
13.40 Cataract surgery in DME patients - Claudio Furino
During the session a lunch box will be distributed
14.15 SESSION III
15.30 Chairman: Francesco Bandello
Facilitators: Felice Cardillo Piccolino, Paolo Lanzetta
14.15 Retinal detachment: different surgical approaches - Matteo Badino
14.25 OCT angiography imaging of eredodistrophy of the macula - Maurizio Battaglia Parodi
14.35 OCT angiography in DME - Francesco Bandello
14.45 CSC management - Massimo Nicolò
14.55 Discussion
15.30 Closing of the meeting
6
6 July 2018 Genoa (Italy) 7 July 2018
_ophthalmology GOA Ophthalmology ESASO Retina Forum
SPONSORED SYMPOSIA
6 JULY 2018
12.30 LUNCH SYMPOSIUM - NOVARTIS
13.30 Ranibizumab appropriate planning to increase long term efficacy
Chairman: Leonardo Mastropasqua
12.30 The treatment of maculopaty after and before Anti-VEGF introduction - Stela Vujosevic
12.40 Ranibizumab long term efficacy: comparison between RCTs and RWE - Maurizio Battaglia Parodi
12.50 Ranibizumab appropriate planning as a strategy to maintain efficacy - Claudio Furino
13.00 Appropriate planning in real practice - Massimo Nicolò
13.15 Take home messages and conclusions
During the session a lunch box will be offered by NOVARTIS
7 JULY 2018
11.00 SYMPOSIUM - BAYER
12.00 Aflibercept and retinal diseases: current role and news from research
Chairmen: Felice Cardillo Piccolino, Paolo Lanzetta
11.00 The role of PLGF in diabetic macular edema - Sandro De Falco
11.15 Aflibercept in wAMD: the experience from clinical practice - Marco Lupidi
11.30 Treat & extend regimen with Aflibercept in wAMD - Paolo Lanzetta
11.45 Diabetic macular edema: the value of Aflibercept - Massimo Nicolò
7
6 July 2018 Genoa (Italy) 7 July 2018
_ophthalmology GOA Ophthalmology ESASO Retina Forum
GENERAL INFORMATION
ORGANIZING SECRETARIAT
OIC srl
Viale G. Matteotti, 7 - 50121 Florence (Italy)
Tel. +39 055 50351
goa2018@oic.it - sponsorGOA@oic.it
www.goaophthalmology2018.org
OIC srl is a MedTech Trusted Partner
COURSE VENUE
Centro Congressi
Auditorium IST NORD - Ospedale Policlinico San Martino
Largo Rosanna Benzi, 10 - 16132 Genova
REGISTRATION DESK
The Registration Desk will be open for registration and information according to the
following schedule:
Friday July 6: from 8.00 to 17.30
Saturday July 7: from 8.30 to 15.30
Participants are kindly requested to collect their Course kit and name badge.
NAME BADGE
Each participant will receive a name badge upon check-in at the registration desk. The
badge will be the official Course pass and should be worn at all times in order to gain entry
into the meeting rooms.
LANGUAGE
The official Course language is English
All participants are encouraged to join discussions, independently of their fluency in
English, as the exchange of ideas and critical evaluation of presentations is the main
purpose of the Course.
8
6 July 2018 Genoa (Italy) 7 July 2018
_ophthalmology GOA Ophthalmology ESASO Retina Forum
GENERAL INFORMATION
SLIDE CENTRE
The Slide Centre is located in the Auditorium. The Auditorium is equipped with a double podium, one
with Windows operating system and one with MacOS High Sierra, both updated with the last version;
for this reason it will not be possible to use personal laptops in the meeting room. Both systems are
compatible with Powerpoint and Keynote.
Speakers are kindly requested to upload their presentation to the Slide Centre during breaks and at
least 2 hours before the beginning of their presentation.
WI-FI
The wifi is active in the Auditorium and in the Foyer of the Auditorium.
It is indicated as “Mac mini di Centro” and no User ID nor password are needed.
LUNCH BOXES
On July 6th and 7th lunch boxes will be provided. Participants will find the tickets for the lunch boxes
collection in their course kit. Lunch boxes will be distributed directly in the Auditorium before the
beginning of the lunch symposia.
Tickets shall be handed to the staff.
CME ACCREDITATION (only for Italian participants)
I crediti formativi ECM saranno certificati dal Provider OIC srl (n. 2836) secondo il nuovo regolamento
approvato dalla Commissione Nazionale per la Formazione Continua il 13 gennaio 2010. L’accreditamento
del Corso sarà effettuato per l’intero evento in un’unica soluzione. Si ricorda che avranno diritto ai crediti
ECM solo coloro che saranno presenti per l’intera durata dell’evento ed avranno compilato gli appositi
questionari che verranno consegnati in sede congressuale. Si ricorda inoltre la determinazione assunta
dalla Commissione Nazionale per la Formazione Continua del 15 Dicembre 2016 alla luce della quale
ogni partecipante potrà maturare 1/3 dei crediti formativi ricondotti al triennio di riferimento (150 totali
per il triennio 2017-2019) mediante reclutamento diretto da parte dello sponsor e dovrà consegnare al
Provider dell’evento una copia dell’invito o una dichiarazione sottoscritta attestante l’invito, con firma
autografa e leggibile unitamente ai propri dati anagrafici.
I crediti assegnati al Corso sono 2,7 e sono rivolti a Medici Specialisti in Oftalmologia, Ortottisti/
Assistenti di Oftalmologia, e Infermieri.
L’obiettivo formativo è: Documentazione clinica. Percorsi clinico-assistenziali, diagnostici e riabilitativi.
Profili di Assistenza – Profili di cura.
La presenza al Corso sarà certificata dalla firma dei registri all’entrata e all’uscita giorno per giorno.
L’assenza di una sola delle firme necessarie determinerà l’impossibilità di assegnazione dei crediti.
Per completare l’acquisizione dei crediti il partecipante dovrà compilare l’apposita modulistica
da ritirare presso il Registration Desk, comprensiva di scheda anagrafica e certificazione di
autoapprendimento nonché il questionario di valutazione dell’evento da compilarsi in forma anonima.
9
6 July 2018 Genoa (Italy) 7 July 2018
_ophthalmology GOA Ophthalmology ESASO Retina Forum
AKNOWLEDGMENTS
omikron
OFTA
PANTONE
3015 C
Cyan 100%
Magenta 30%
Giallo 0%
Nero 20%
The following scientific contribution is
organized thanks to the unrestricted educational grant of:
7 July 2018 - 13:00/14:00
LUNCH BREAK SYMPOSIUM:
Cataract surgery in diabetic macular edema or glaucoma patients: new perspectives
106 July 2018 Genoa (Italy) 7 July 2018
_ophthalmology GOA Ophthalmology ESASO Retina Forum
116 July 2018 Genoa (Italy) 7 July 2018 _ophthalmology GOA Ophthalmology ESASO Retina Forum Omikron Italia is an Italian Pharmaceutical Company specialized in Ophtalmology, founded in 2005 and registered as Pharmaceutical Industry at the Italian Medicine Agency (Agenzia Italiana del Farmaco) (SIS code 2841). Omikron Italia is an organization with certified management system in accordance with UNI EN ISO 9001:2008 and UNI EN ISO 13485:2012 and compliant with the requirements of Farmindustria Guidelines on the Scientific Information Activities. 20% of the total Company turnover is realized abroad. Every year Omikron Italia invests about 12% of its turnover in R&D through which the most important trials on Neuroprotection in Glaucoma were performed and the International Patent for Citicoline in eye drops was obtained. Omikron Italia recently registered and launched on the market the first Oral Neuroprotective product (Product for Special Medical Purposes) with approved Therapeutic Indication for Glaucoma. Finally, Omikron Italia won a research grant provided by the Ministry for Education, University and Research (MIUR) for the Clinical Research (art.11) in partnership with an Italian University Institute. In Italy the Medical Scientific Information is perfomed by a team of 30 Sales Representatives constantly trained and fulfilling the requirements as per the Directive 2001/83/EC and subsequent amendments. Omikron Italia S.r.l. Viale Bruno Buozzi, 5 Tel. 06 80693572 - Fax 06 80665266 00197 Roma info@omikronitalia.it - www.omikronitalia.it 12
6 July 2018 Genoa (Italy) 7 July 2018
_ophthalmology GOA Ophthalmology ESASO Retina Forum
143P - S0618
13Puoi anche leggere
